Search Ontology:
ChEBI
rigosertib sodium
- Term ID
- CHEBI:145421
- Synonyms
-
- (E)-ON 01910.Na
- Estybon
- novonex
- ON 01910 sodium
- ON 01910 sodium salt
- ON 01910.Na
- ON-01910 sodium
- ON-01910 sodium salt
- ON-01910.Na
- rigosertib sodium salt
- sodium [2-methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)anilino]acetate
- Definition
- The sodium salt of rigosertib. It is an anti-cancer agent which has been granted Orphan Drug Designation by the FDA for use in patients with myelodysplastic syndromes (MDS).
- References
-
- CAS:592542-60-4
- DrugBank:DBSALT002144
- KEGG:D10155
- PMID:15766665
- PMID:17588831
- PMID:18955447
- PMID:19029951
- PMID:19466411
- PMID:21646468
- PMID:21812421
- PMID:21924492
- PMID:22351695
- PMID:22524974
- PMID:22678771
- PMID:23386308
- PMID:23486532
- PMID:23738723
- PMID:23841031
- PMID:24493827
- PMID:24748653
- PMID:25316768
- PMID:27150054
- PMID:27764820
- PMID:28985505
- PMID:29423069
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from rigosertib sodium
Phenotype where environments contain rigosertib sodium
Phenotype modified by environments containing rigosertib sodium
Human Disease Model